Intranasal Ivermectin Spray, the Sunscreen to COVID-19

Throughout the battle against SARS-CoV-2 (COVID-19), various medications have been repurposed in hopes of finding a successful treatment modality to combat global pandemic. One medication that has recently begun show promising advancement clinical trials is well-known anti-parasitic medication, ivermectin. In this review, we delve into ivermectin and its use as therapeutic agent COVID-19. The foundation how treats COVID-19 lies ability inhibit viral replication process. After assessing mechanism, pharmacokinetic properties, current uses ivermectin, hypothesized administering intranasally would best capitalize on inhibitory qualities while avoiding dangerous dosages be achieved with oral treatment. Therefore, propose early limit severity, well prophylactic administration protect those high-exposure environments.